Cleared Traditional

K161586 - The JLN-23XX Series Piston Compress Nebulizer (with models JLN-2300AS, JLN-2301AS, JLN-2317AS and JLN-2320AS)

K161586 is an FDA 510(k) clearance for The JLN-23XX Series Piston Compress Neb..., manufactured by Shenzhen Homed Medical Device Co., Ltd.. The device is a Class 2 Anesthesiology device with product code CAF cleared through the Traditional 510(k) pathway after a 455-day FDA review.

K161586 · Shenzhen Homed Medical Device Co., Ltd. · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2017
Decision
455d
Days
Class 2
Risk

K161586 is an FDA 510(k) clearance for the The JLN-23XX Series Piston Compress Nebulizer (with models JLN-2300AS, JLN-23.... Classified as Nebulizer (direct Patient Interface) (product code CAF), Class II - Special Controls.

Submitted by Shenzhen Homed Medical Device Co., Ltd. (Shenzhen, CN). The FDA issued a Cleared decision on September 6, 2017 after a review of 455 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.5630 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Anesthesiology submissions.

View all Shenzhen Homed Medical Device Co., Ltd. devices

FDA 510(k) Submission Details - K161586

510(k) Number K161586 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 08, 2016
Decision Date September 06, 2017
Days to Decision 455 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
315d slower than avg
Panel avg: 140d · This submission: 455d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CAF Device Classification - Class 2, Special Controls

Product Code CAF Nebulizer (direct Patient Interface)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.5630
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - CAF Nebulizer (direct Patient Interface)

All 407
Devices cleared under the same product code (CAF) and FDA review panel - the closest regulatory comparables to K161586.
MC 300* Nebulizer
K173367 · Trudell Medical International · Feb 2018
Portable Nebulizer
K170916 · Microbase Technology Corporation · Nov 2017
InnoSpire Go
K170853 · Respironics Respiratory Drug Delivery (Uk) , Ltd. · Nov 2017
SmartTouch
K163485 · Adherium (Nz), Ltd. · Aug 2017
AirLife Misty Finity Nebulizer
K153748 · Care Fusion · May 2017
Airworks Nebulizer pe1200m
K162041 · Convexity Scientific, LLC · May 2017